ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,631.22
      0.28%
      US Tech 100
      19,814.80
      -0.16%
      Dow Jones
      40,211.72
      0.53%
      Brent Oil
      83.575
      -0.91%
      Bitcoin
      62,637.87
      -3.41%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Mesoblast Limited (MESO)

      7. Mesoblast Limited (MESO) News

      MESO

      Mesoblast (MESO)

      Mesoblast Limited
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:MESO
      DateTimeSourceHeadlineSymbolCompany
      08/28/20189:04PMGlobeNewswire Inc.Mesoblast Provides Update on Transaction With Tasly Pharmaceutical GroupNASDAQ:MESOMesoblast Limited
      08/02/20186:16AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      07/24/20186:05AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      07/19/20186:04AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      07/17/20186:32AMGlobeNewswire Inc.Mesoblast Enters Into Strategic Cardiovascular Alliance for China With Tasly Pharmaceutical GroupNASDAQ:MESOMesoblast Limited
      07/13/20186:05AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      07/11/20186:00AMGlobeNewswire Inc.Leading Commercial and Transactional Healthcare Executive Shawn Cline Tomasello Joins Mesoblast BoardNASDAQ:MESOMesoblast Limited
      07/02/20186:00AMGlobeNewswire Inc.Mesoblast Enters Into US$50M Financing with Novaquest Capital for Commercial Readiness of Remestemcel-l in the Treatment of A...NASDAQ:MESOMesoblast Limited
      06/28/20186:07AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      06/22/20189:35AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      06/21/20186:00AMGlobeNewswire Inc.Key Day 100 Survival Outcomes of Phase 3 Trial for Acute Graft Versus Host Disease Presented at 2018 ISSCR Annual MeetingNASDAQ:MESOMesoblast Limited
      06/20/20186:07AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      06/19/20186:00AMGlobeNewswire Inc.U.S. Healthcare Leader Joseph R. Swedish Joins Mesoblast BoardNASDAQ:MESOMesoblast Limited
      06/01/20186:09AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      06/01/20186:09AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      05/30/20187:32PMGlobeNewswire Inc.Financial Results and Operational Highlights for the Third Quarter Ended March 31, 2018NASDAQ:MESOMesoblast Limited
      05/30/20186:41PMGlobeNewswire Inc.Mesoblast Appoints New Chief Financial OfficerNASDAQ:MESOMesoblast Limited
      05/30/20186:09AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      05/29/20183:21PMGlobeNewswire Inc.Mesoblast Financial Results Webcast for Quarter Ended March 31, 2018NASDAQ:MESOMesoblast Limited
      05/29/20186:00AMGlobeNewswire Inc.Mesoblast Partners With Cartherics to Develop ’off-the-shelf’ Cell-based Immunotherapies for Solid CancersNASDAQ:MESOMesoblast Limited
      05/18/20186:06AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      05/10/20186:16AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      05/08/20186:00AMGlobeNewswire Inc.Mesoblast Phase 3 Trial Results for Acute Graft Versus Host Disease Presented at 2018 International Society for Cell and Gen...NASDAQ:MESOMesoblast Limited
      05/04/20187:51AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      05/02/20189:33AMGlobeNewswire Inc.Mesoblast Cell Therapies Featured at Vatican International Healthcare ConferenceNASDAQ:MESOMesoblast Limited
      04/20/20186:07AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      04/18/20186:00AMGlobeNewswire Inc.Mesoblast Clinical Program Update for MPC-150-IM in Patients With Chronic Heart FailureNASDAQ:MESOMesoblast Limited
      03/30/20188:18AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      03/28/20186:25PMGlobeNewswire Inc.Mesoblast Phase 3 Cell Therapy Trial for Chronic Low Back Pain Completes EnrollmentNASDAQ:MESOMesoblast Limited
      03/08/20186:10AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
       Showing the most relevant articles for your search:NASDAQ:MESO